Baillie Gifford & CO Moderna, Inc. Transaction History

Baillie Gifford & CO

  • $128 Billion
  • Q3 2025

A detailed history of Baillie Gifford & CO transactions in Moderna, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 21,846,666 shares of MRNA stock, worth $593 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
21,846,666
Previous 22,094,124 1.12%
Holding current value
$593 Million
Previous $610 Million 7.43%
% of portfolio
0.44%
Previous 0.48%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025
SELL
$23.51 - $34.67 $5.82 Million - $8.58 Million
-247,458 Reduced 1.12%
21,846,666 $564 Million
Q2 2025

Aug 06, 2025
SELL
$23.65 - $28.54 $67.5 Million - $81.5 Million
-2,854,434 Reduced 11.44%
22,094,124 $610 Million
Q1 2025

May 07, 2025
SELL
$28.35 - $47.53 $395 Million - $663 Million
-13,941,013 Reduced 35.85%
24,948,558 $707 Million
Q4 2024

Jan 31, 2025
SELL
$36.85 - $63.93 $131 Million - $228 Million
-3,568,512 Reduced 8.4%
38,889,571 $1.62 Billion
Q3 2024

Nov 05, 2024
SELL
$63.64 - $125.14 $63.1 Million - $124 Million
-990,958 Reduced 2.28%
42,458,083 $2.84 Billion
Q2 2024

Jul 25, 2024
SELL
$101.21 - $166.61 $122 Million - $201 Million
-1,206,776 Reduced 2.7%
43,449,041 $5.16 Billion
Q1 2024

May 01, 2024
SELL
$85.37 - $115.44 $85.3 Million - $115 Million
-998,710 Reduced 2.19%
44,655,817 $4.76 Billion
Q4 2023

Jan 26, 2024
BUY
$69.51 - $104.43 $371,461 - $558,073
5,344 Added 0.01%
45,654,527 $4.54 Billion
Q3 2023

Nov 13, 2023
SELL
$96.41 - $126.61 $5.97 Million - $7.84 Million
-61,912 Reduced 0.14%
45,649,183 $4.72 Billion
Q2 2023

Jul 28, 2023
SELL
$118.5 - $160.53 $89.5 Million - $121 Million
-755,076 Reduced 1.63%
45,711,095 $5.55 Billion
Q1 2023

May 03, 2023
BUY
$135.66 - $197.02 $228 Million - $331 Million
1,679,425 Added 3.75%
46,466,171 $7.14 Billion
Q4 2022

Jan 24, 2023
SELL
$118.38 - $210.04 $58.4 Million - $104 Million
-493,277 Reduced 1.09%
44,786,746 $8.04 Billion
Q3 2022

Oct 27, 2022
SELL
$118.07 - $194.18 $33 Million - $54.3 Million
-279,768 Reduced 0.61%
45,280,023 $5.35 Billion
Q2 2022

Aug 08, 2022
SELL
$117.13 - $176.59 $8.13 Million - $12.3 Million
-69,435 Reduced 0.15%
45,559,791 $6.51 Billion
Q1 2022

May 05, 2022
SELL
$126.46 - $235.05 $18.1 Million - $33.6 Million
-142,853 Reduced 0.31%
45,629,226 $7.86 Billion
Q4 2021

Jan 20, 2022
BUY
$225.82 - $368.51 $803 Million - $1.31 Billion
3,554,725 Added 8.42%
45,772,079 $11.6 Billion
Q3 2021

Oct 19, 2021
SELL
$221.9 - $484.47 $813 Million - $1.78 Billion
-3,665,859 Reduced 7.99%
42,217,354 $16.2 Billion
Q2 2021

Aug 02, 2021
BUY
$129.91 - $234.98 $70.9 Million - $128 Million
545,449 Added 1.2%
45,883,213 $10.8 Billion
Q1 2021

May 06, 2021
BUY
$109.18 - $185.98 $2.3 Billion - $3.91 Billion
21,025,493 Added 86.48%
45,337,764 $5.94 Billion
Q4 2020

Feb 10, 2021
BUY
$65.74 - $169.86 $1.12 Billion - $2.9 Billion
17,086,635 Added 236.47%
24,312,271 $2.54 Billion
Q3 2020

Nov 12, 2020
BUY
$54.34 - $94.85 $172 Million - $300 Million
3,166,153 Added 77.99%
7,225,636 $511 Million
Q2 2020

Aug 12, 2020
BUY
$29.67 - $80.0 $14.8 Million - $40 Million
499,599 Added 14.03%
4,059,483 $261 Million
Q1 2020

May 08, 2020
BUY
$17.78 - $31.58 $2.56 Million - $4.54 Million
143,771 Added 4.21%
3,559,884 $107 Million
Q4 2019

Feb 10, 2020
BUY
$13.93 - $21.28 $2.8 Million - $4.28 Million
201,316 Added 6.26%
3,416,113 $66.8 Million
Q3 2019

Nov 07, 2019
BUY
$12.26 - $18.07 $88,296 - $130,140
7,202 Added 0.22%
3,214,797 $51.2 Million
Q2 2019

Aug 08, 2019
BUY
$13.7 - $28.34 $8.66 Million - $17.9 Million
632,394 Added 24.56%
3,207,595 $47 Million
Q1 2019

May 01, 2019
BUY
$14.45 - $23.7 $12.3 Million - $20.1 Million
849,357 Added 49.21%
2,575,201 $0
Q4 2018

Feb 14, 2019
BUY
$13.52 - $18.8 $23.3 Million - $32.4 Million
1,725,844 New
1,725,844 $26.4 Million

Others Institutions Holding MRNA

# of Institutions
857
Shares Held
266M
Call Options Held
28.5M
Put Options Held
34.9M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $10.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email